The Synergy of AI: Screening & Diagnostics on Steroids!

Computer vision in medical imaging: how AI systems accelerate screening and diagnostic workflows while managing the false-positive rates that determine clinical acceptance.

The Synergy of AI: Screening & Diagnostics on Steroids!
Written by TechnoLynx Published on 03 May 2024

Introduction: AI’s Role in Healthcare and Medicine

The healthcare field is definitely one of the most respected worldwide, which is why the healthcare industry is so big! Physicians and healthcare professionals have been respected since ancient times. How ancient? Well, the world-famous Hippocratic Oath dates back to the 4th century BC. ‘I will use therapy which will benefit my patients according to my greatest ability and judgment, and I will do no harm or injustice to them’, says the Oath (Greek Medicine, no date).

Figure 1 – Concept image of a robot shaking hands with a human (Evaluation of AI for medical imaging: A key requirement for clinical translation, 2022)
Figure 1 – Concept image of a robot shaking hands with a human (Evaluation of AI for medical imaging: A key requirement for clinical translation, 2022)

We have seen how medicine has changed over the years. Our society has evolved from digesting roots and trepanning for therapeutic purposes to visualising our internals with cutting-edge technology that produces extremely crisp images. What is the next step? The integration of AI into our arsenal for medical decisions, of course! Keep scrolling to find out more.

With Proper Training Comes Great Results

The first thing most people think about when they hear the word AI is something high-tech, and you know what? They would be right! AI is the theory and development of computer systems capable of performing tasks that normally require human intelligence, such as visual perception, speech recognition, decision-making, and language translation. ‘And how is that achieved?’ we hear you ask. The answer is hidden in a method you have probably already heard of that teaches computers to process data in a way inspired by the human brain: Deep Learning (DL). Before we dive deeper, we need to get a little technical, possibly geeky. We know you came here for the main course, but, trust us, you will find the appetiser very interesting.

Figure 2 – Illustration of a robot thinking while trying to solve mathematical calculations (Building smarter machines, 2019)
Figure 2 – Illustration of a robot thinking while trying to solve mathematical calculations (Building smarter machines, 2019)

“I Will Make a ‘Man’ Out of You!”

Each AI algorithm needs proper training to perform its wonders. Optimally, this is achieved by creating an algorithm that can be trained on hundreds of thousands, if not millions, of data. To do that, we first must ensure that the data we feed the algorithm properly. This means that the data must be collected from various sources, such as databases, and that the data are ‘clean’. To do that, we need to check that there are no missing values or inconsistencies, that the classes are meaningful, and the labels are correct. The data are then transformed with techniques that normalise them, reduce their dimensions, or augment the data while ensuring no information is lost or wrongfully duplicated. Finally, the data are divided into train and test sets, and adjustments are made to ensure maximum accuracy with the minimum number of resources used. So far so good? Nice! Let’s move on.

Going beyond human!

We might want to make the most efficient and infallible AI algorithm for medical imaging. But what happens when the data are simply not enough? Well, it is not called AI for no reason! One of the best features of AI is Data Augmentation (DA). Generative AI models can alter existing data to generate new ones, but that is not all! One of the most powerful features of generative AI is Synthetic Image Generation (SIG). The difference between DA and SIG is that, instead of altering existing medical images, SIG can create synthetic medical images using the limited resources it has been provided with. Bless creativity!

The Incorporation of AI in Modern Medical Tech

Deep Learning (DL) and Computer Vision (CV), a GPU-accelerated pipeline of AI, have been used extensively in medical facilities by integrating them into medical Decision Support Systems (DSS). Such systems are embossed in most modern medical tech gear with the sole purpose of helping physicians and medical staff make the right decision at the right time. AI is defined by its ability to learn from large datasets and make decisions. Its computational power on numbers could be analogous to what we humans call ‘experience’. AI algorithms can run through millions of patient records and make decisions about their health status simply by looking at the input data. Although the results can be stunning, there is a way to push this beyond limits, called ‘Edge Computing’. Medical facilities have their servers and databases for the localised processing of data. Having them up to date hardware-wise allows the processing power to be maximised while minimising the time consumption. In this way, we optimise the performance of the AI algorithm with instantaneous results!

I See it All, I Know it All!

Medical imaging is one of the fanciest applications of CV. At least once in your life, you surely have had to have an X-ray, right? If you recall, the doctor would place your X-ray in a view box and carefully try to identify possible abnormalities. That’s ok, for sure, but is it even allowed in the digital age? Modern-age doctors have been shown to prefer DSS algorithms over the standard procedure that has been followed for many years. The reason is very simple: automation. CV can be trained to perform image analysis to automatically detect these abnormalities. Notice that we said ‘detect’. Not only can it identify which image has an abnormality, but it can also pinpoint with extreme precision where the abnormality is located! In one phrase: Computer-Aided Diagnosis (CAD). With a well-trained DSS pipeline, CV‘s benefits are multiple: Time-saving? Check! More accurate? Double check! The best part is that such algorithms can be set to be trained by learning from their mistakes. A doctor would not risk a machine-caused error. By interacting with the algorithm, it can be taught to recognise and never repeat the same mistake in real time!

Figure 3 – Cerebrospinal fluid MRI scan where different areas of the brain are colour-coded using DL (‘Aging-related volume changes in the brain and cerebrospinal fluid using AI-automated segmentation - AI Blog - ESR | European Society of Radiology %’, no date)
Figure 3 – Cerebrospinal fluid MRI scan where different areas of the brain are colour-coded using DL (‘Aging-related volume changes in the brain and cerebrospinal fluid using AI-automated segmentation - AI Blog - ESR | European Society of Radiology %’, no date)

My Game, my Rules… My Risks?

Although we have shown what practical applications AI can have in medical imaging and CAD, nothing comes without a cost. As mentioned, great training comes with great results, but let us not forget that ‘with great power comes great responsibility’. Such a powerful tool as AI has its risks that must be addressed. And no, we will not talk about AI taking over and leaving us unemployed. The thing is that even though AI is so smart, it can sometimes be challenging to train. The challenges lie mostly in the lack of data, which, surely enough, can be countered with DA and SIG, as we already mentioned. However, the biggest threat to AI is something that you might or might not expect. If your guess was ‘humans’, you would be right. Human error remains a threat to the proper training and use of AI. Think of AI as a recipe for food. Despite executing it word by word, the meal will be a disaster if you add a ton of salt and pepper! Now take this and multiply it by a zillion times. After all, we are talking about human lives. Automation is good and all, but if a tiny issue can mess up one patient’s results, imagine what it would do to an entire medical facility with thousands of them.

Figure 4 – An image of a physician interacting with his AI-loaded portable device (How AI Helps Physicians Improve Telehealth Patient Care in Real-Time | telemedicine.arizona.edu, no date)
Figure 4 – An image of a physician interacting with his AI-loaded portable device (How AI Helps Physicians Improve Telehealth Patient Care in Real-Time | telemedicine.arizona.edu, no date)

Summing Up

AI is a powerful ally in the field of medicine and healthcare. It can perform classification and segmentation tasks on medical images and screening, generate artificial images, and even correct its errors. In a nutshell, AI can undoubtedly almost run the diagnostics of an entire medical imaging facility on its own. By providing enough training information and having the necessary resources, there is no task AI cannot do.

What We Offer

At TechnoLynx, we specialise in delivering custom, innovative tech solutions tailored to any challenge because we understand the benefits of integrating AI into medical applications and healthcare institutions. Our expertise covers improving AI capabilities, ensuring safety in human-machine interactions, managing and analysing extensive data sets, and addressing ethical considerations.

We offer precise software solutions designed to empower AI-driven algorithms in various industries. Our commitment to innovation drives us to adapt to the ever-evolving AI landscape. We provide cutting-edge solutions that increase efficiency, accuracy, and productivity. Feel free to contact us. We will be more than happy to answer any questions!

List of references

Digital Shelf Monitoring with Computer Vision: What Retail AI Actually Detects

Digital Shelf Monitoring with Computer Vision: What Retail AI Actually Detects

7/05/2026

Digital shelf monitoring uses CV to detect out-of-stocks, planogram compliance, and pricing errors. What the systems actually detect and where accuracy drops.

EU GMP Annex 11: What It Requires for Computerised Systems in Pharma

EU GMP Annex 11: What It Requires for Computerised Systems in Pharma

7/05/2026

EU GMP Annex 11 governs computerised systems in pharma manufacturing. Its data integrity, validation, and access control requirements are specific.

Deep Learning for Image Processing in Production: Architecture Choices, Training, and Deployment

Deep Learning for Image Processing in Production: Architecture Choices, Training, and Deployment

7/05/2026

Deep learning for image processing in production: CNN vs ViT tradeoffs, training data requirements, augmentation, deployment optimisation, and.

Drug Manufacturing: How Pharmaceutical Production Works and Where AI Adds Value

Drug Manufacturing: How Pharmaceutical Production Works and Where AI Adds Value

7/05/2026

Drug manufacturing transforms APIs into finished products through formulation, processing, and packaging. AI improves process control, inspection, and.

AI vs Real Face: Anti-Spoofing, Liveness Detection, and When Custom CV Models Are Necessary

AI vs Real Face: Anti-Spoofing, Liveness Detection, and When Custom CV Models Are Necessary

7/05/2026

When synthetic faces defeat pretrained detectors: anti-spoofing challenges, liveness detection requirements, and when custom models are unavoidable.

Continuous Manufacturing in Pharma: How It Works and Why AI Is Essential

Continuous Manufacturing in Pharma: How It Works and Why AI Is Essential

7/05/2026

Continuous pharma manufacturing replaces batch processing with real-time flow. AI-based process control is essential for maintaining quality in continuous.

AI-Based CCTV Monitoring Solutions: Automation vs Human Review and What Each Handles Well

AI-Based CCTV Monitoring Solutions: Automation vs Human Review and What Each Handles Well

7/05/2026

AI CCTV monitoring vs human monitoring: cost comparison, coverage capability, response time tradeoffs, and what AI handles well vs where human judgment is.

Computer System Validation in Pharma: What Engineering Teams Need to Implement

Computer System Validation in Pharma: What Engineering Teams Need to Implement

7/05/2026

Computer system validation in pharma requires documented evidence of fitness for use. CSA now offers a risk-based alternative to full CSV for lower-risk.

CCTV Face Recognition in Production: Why It Fails More Than Demos Suggest

CCTV Face Recognition in Production: Why It Fails More Than Demos Suggest

7/05/2026

CCTV face recognition: resolution requirements, angle and lighting challenges, false positive rates, GDPR compliance, and why production performance lags.

cGMP vs GMP: What the Difference Means for Pharmaceutical Manufacturing

cGMP vs GMP: What the Difference Means for Pharmaceutical Manufacturing

6/05/2026

cGMP is the FDA's evolving standard for manufacturing quality. GMP is the broader WHO/EU framework. The 'current' modifier changes what compliance means.

AI-Enabled CCTV for Building Security: Analytics, Camera Placement, and Infrastructure

AI-Enabled CCTV for Building Security: Analytics, Camera Placement, and Infrastructure

6/05/2026

AI CCTV for building security: intrusion detection, people counting, loitering analytics, camera placement strategy, and storage and bandwidth.

cGMP in Pharmaceutical Manufacturing: What the Regulations Actually Require

cGMP in Pharmaceutical Manufacturing: What the Regulations Actually Require

6/05/2026

cGMP pharmaceutical regulations define minimum quality standards for drug manufacturing. Compliance requires documentation, process control, and personnel.

Best Wired CCTV Systems for AI Video Analytics: What Matters Beyond Resolution

6/05/2026

Wired CCTV systems for AI analytics need more than high resolution. Codec support, edge processing, and integration architecture determine analytics quality.

Automated Visual Inspection in Pharma: How CV Systems Replace Manual Quality Checks

6/05/2026

Automated visual inspection in pharma uses computer vision to detect defects in vials, syringes, and tablets — faster and more consistently than human.

Automated Visual Inspection Systems: Hardware, Model Selection, and False-Reject Rates

6/05/2026

Build automated visual inspection systems that work: hardware setup, model selection (classification vs detection vs segmentation), and managing.

Aseptic Manufacturing in Pharma: Process Control, Risks, and Where AI Fits

6/05/2026

Aseptic manufacturing prevents microbial contamination during sterile drug production. AI monitoring addresses the environmental control gaps humans miss.

4K Security Cameras and AI Analytics: When Higher Resolution Helps and When It Doesn't

6/05/2026

4K security cameras for AI analytics: bandwidth and storage costs, where higher resolution improves results, compression artifacts and AI accuracy.

Computer Vision in Pharmacy Retail: Inventory Tracking, Planogram Compliance, and Shrinkage Reduction

5/05/2026

CV in pharmacy retail addresses unique challenges: regulated product tracking, controlled substance security, and planogram compliance across thousands of SKUs.

Visual Inspection Equipment for Manufacturing QC: Where AI Adds Value and Where Rules Still Win

5/05/2026

AI-enhanced visual inspection replaces rule-based defect detection with learned representations — but requires validated training data matching production variability.

AI-Driven Pharma Compliance: From Manual Documentation to Continuous Validation

5/05/2026

AI shifts pharma compliance from periodic manual audits to continuous automated validation — catching deviations in hours instead of months.

AI Enables Real-Time Monitoring of Aseptic Filling Lines — Here's What's Changing

5/05/2026

New AI-driven monitoring systems detect contamination risk in aseptic filling by analysing environmental and process data continuously rather than via batch sampling.

Facial Recognition in Video Surveillance: Why Lab Accuracy Doesn't Transfer to CCTV

5/05/2026

Facial recognition accuracy drops 10–40% between controlled enrollment conditions and production CCTV due to angle, lighting, and resolution.

Computer Vision Store Analytics: What Cameras Can Actually Measure in Retail

5/05/2026

Store analytics CV must distinguish 'detected' from 'measured with business-decision confidence.' Most deployments conflate the two.

AI in Pharmaceutical Supply Chains: Where Computer Vision and Predictive Analytics Deliver ROI

5/05/2026

Pharma supply chain AI delivers measurable ROI in three areas: serialisation verification, cold-chain anomaly prediction, and visual inspection automation.

Computer Vision for Retail Loss Prevention: What Works, What Breaks, and Why Scale Matters

5/05/2026

CV-based loss prevention must handle thousands of SKUs under variable lighting. Single-model approaches produce unactionable alert volumes at scale.

GxP Regulations Explained: What They Mean for AI and Software in Pharma

5/05/2026

GxP is a family of regulations — GMP, GLP, GCP, GDP — each applying different validation requirements to AI systems depending on lifecycle role.

Intelligent Video Analytics: How Modern CCTV Systems Detect Behaviour Instead of Motion

4/05/2026

IVA shifts surveillance alerting from pixel-change detection to behaviour understanding. But only modular pipeline architectures deliver this in practice.

Pharma POC Methodology That Survives Downstream GxP Validation

2/05/2026

A pharma AI POC that survives GxP validation: five instrumentation choices made at week one, removing the 6–9 month re-derivation at validation handover.

Cross-Platform TTS Inference Under Real-Time Constraints: ONNX and CoreML

1/05/2026

Cross-platform TTS to iOS, Android and browser stays consistent only if compression is decided at training time — distill once, export to ONNX.

Production Anomaly Detection in Video Data Pipelines: A Generative Approach

1/05/2026

Generative models trained on normal frames detect rare video anomalies without labelled anomaly data — reconstruction error is the score.

Designing Observable CV Pipelines for CCTV: Modular Architecture for Security Operations

30/04/2026

Operators stop trusting CV alerts when the pipeline is opaque. Observable, modular CCTV pipelines decompose decisions into auditable stages.

The Unknown-Object Loop: Designing Retail CV Systems That Improve Operationally

30/04/2026

Retail CV deployments meet products outside the training catalogue. The architectural choice: silent misclassification or a designed review loop.

Why Client-Side ML Projects Miss Latency Targets Before Deployment

29/04/2026

Client-side ML misses latency targets when the device capability baseline is set after architecture selection rather than before. Sequence matters.

Building a Production SKU Recognition System That Degrades Gracefully

29/04/2026

Graceful degradation in production SKU recognition is an architectural property: predictable automation rate as the catalogue grows.

Why AI Video Surveillance Generates False Alarms — And What Pipeline Architecture Reduces Them

28/04/2026

Surveillance false alarms are an architecture problem, not a sensitivity setting. Modular pipelines reduce them; monolithic ones cannot.

Why Computer Vision Fails at Retail Scale: The Compound Failure Class

28/04/2026

CV models that pass accuracy tests at 500 SKUs fail in production above 1,000 — not from one cause but from four simultaneous failure axes.

When to Build a Custom Computer Vision Model vs Use an Off-the-Shelf Solution

26/04/2026

Custom CV models are justified when the domain is specialised and off-the-shelf accuracy is insufficient. Otherwise, customisation adds waste.

How to Deploy Computer Vision Models on Edge Devices

25/04/2026

Edge CV trades accuracy for latency and bandwidth savings. Quantisation, model selection, and hardware matching determine whether the trade-off works.

EU GMP Annex 11 Requirements for Computerised Systems in Pharmaceutical Manufacturing

25/04/2026

Annex 11 governs computerised systems in EU pharma manufacturing. Its data integrity requirements and AI implications are more specific than teams assume.

What ROI Computer Vision Actually Delivers in Retail

24/04/2026

Retail CV ROI comes from shrinkage reduction, planogram compliance, and checkout automation — not AI dashboards. Measure what changes operationally.

How to Classify and Validate AI/ML Software Under GAMP 5 in GxP Environments

24/04/2026

GAMP 5 categories were designed for deterministic software. AI/ML systems require the Second Edition's risk-based approach and continuous validation.

Data Quality Problems That Cause Computer Vision Systems to Degrade After Deployment

23/04/2026

CV system degradation after deployment is usually a data problem. Annotation inconsistency, domain shift, and data drift are the structural causes.

How Computer Vision Replaces Manual Visual Inspection in Pharmaceutical Quality Control

23/04/2026

CV-based pharma QC inspection is a production engineering problem, not a model accuracy problem. It requires data, validation, and pipeline design.

How to Architect a Modular Computer Vision Pipeline for Production Reliability

22/04/2026

A production CV pipeline is a system architecture problem, not a model accuracy problem. Modular design enables debugging and component-level maintenance.

Proven AI Use Cases in Pharmaceutical Manufacturing Today

22/04/2026

Pharma manufacturing AI is deployable now — process control, visual inspection, deviation triage. The approach is assessment-first, not technology-first.

Machine Vision vs Computer Vision: Choosing the Right Inspection Approach for Manufacturing

21/04/2026

Machine vision is deterministic and auditable. Computer vision is adaptive and generalisable. The choice depends on defect complexity, not preference.

What GxP Compliance Actually Requires for AI Software in Pharmaceutical Manufacturing

21/04/2026

GxP applies to AI software that affects product quality, safety, or data integrity — not to every system in a pharma facility. The boundary matters.

The Real Cost of Pharmaceutical Batch Failure and How AI Prevents It

21/04/2026

Pharmaceutical batch failures cost waste, rework, and regulatory exposure. AI-based process control prevents the failure classes behind most rejections.

Back See Blogs
arrow icon